Company Overview
Oxylabs is a Lithuania-based provider of proxy infrastructure and web-scraping tools that enable large-scale automated data collection. The company operates primarily in the EU and North America, serving enterprise clients that require structured web data for AI training, market intelligence, and competitive monitoring. With revenue below €10M, Oxylabs remains an early-stage business despite its infrastructure scale and global proxy network.
Deal Context
The €113.6M growth-equity round led by Warburg Pincus positions Oxylabs as a premium asset in the consolidating data-infrastructure sector. The transaction is classic growth equity rather than founder succession or acqui-hire. Likely follow-on buyers include strategic data platforms (e.g., SimilarWeb, Bright Data) or larger software groups seeking proprietary scraping capabilities. The round size and investor caliber signal a clear path to either a secondary sale or eventual strategic exit within 4–6 years.
Valuation Context
Baltic listed peers trade at 5.6–15.1x EV/EBITDA, with a median near 8x. Applying a 30–40% private-company discount yields 4–6x EBITDA as a realistic ceiling for Oxylabs today. Given sub-€10M revenue and high growth, a 12–18x forward revenue multiple is more relevant, implying a post-money valuation of €150–200M. This remains aggressive relative to Baltic comps but consistent with AI-data multiples observed in Western Europe.
Triage Verdict
GO
- Fit: Strong sector tailwinds, largest Baltic tech round of the period, and clear strategic-buyer appeal align with mandate for scalable data assets.
- Red flags: Sub-€10M revenue base creates execution and customer-concentration risk; limited public operating history raises key-man and churn concerns.
- Next step: Request data room for ARR, gross-margin, and churn metrics; initiate founder outreach via local network.
Key Risk
Regulatory tightening on automated scraping in the EU and US could materially impair the core product and slow client adoption.
Bottom line: Premium-priced growth equity in a hot vertical—proceed to diligence.
| # | Fund | AUM | YTD | Positions |
|---|---|---|---|---|
| 1 | Ma Investment Partnership, LP | $322.6B | +190.8% | 18 |
| 2 | Graticule Asia Macro Advisors LLC | $1.1T | +163.2% | 4 |
| 3 | Shengqi Capital (Hong Kong) Ltd | $95.6B | +160.1% | 10 |
| 4 | Anther Capital Ltd | $3.8T | +159.9% | 31 |
| 5 | Central Asset Investments & Manag… | $261.4B | +147.0% | 63 |
| 6 | Oxbow Capital Management (HK) Ltd | $731.4B | +142.6% | 14 |
| 7 | Panoramic Hills Capital Ltd | $835.3B | +118.9% | 6 |
| 8 | Grand Alliance Asset Management Ltd | $302.6B | +118.8% | 24 |
| 9 | AIHC Capital Management Ltd | $226.4B | +114.4% | 11 |
| 10 | Step Capital Management Pte. Ltd. | $467.4B | +113.7% | 53 |
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Pelican Acquisition II Corp | PLCIU | UNKNOWN | TBD | $86.2M |
| Cartesian Growth Corp IV | CGCFU | UNKNOWN | TBD | $287.5M |
| Research Alliance Corp IV | RACD | UNKNOWN | TBD | $75.0M |
| GLGHK Ltd | GLG | UNKNOWN | TBD | $40.2M |
| Company | Sector | Valuation |
|---|---|---|
| Anthropic | Artificial Intelligence | $965.0B |
| OpenAI | Artificial Intelligence | $894.3B |
| Databricks | Data and Analytics | $193.3B |
# IC Memo Writer You draft an investment-committee memo that an IC will actually read and approve. ## Structure (keep each section tight) **Executive Summary (< 200 words)** - Recommendation: APPROVE / APPROVE WITH CONDITIONS / REJECT - Headline EV, equity check, leverage, IRR / MOIC - 3-bullet thesis - 3-bullet risks **Investment Thesis** - Market opportunity and TAM growth - Competitive position and moat - Growth vectors (organic, M&A, margin expansion) - Management assessment **Financial Analysis** - LTM + projected financials - Valuation (DCF + multiples ranges) - Returns at base / bu…